Skip to content

A randomized non-inferiority clinical trial comparing superior trunk block and interscalene brachial plexus block for arthroscopic shoulder surgery

A randomized non-inferiority clinical trial comparing superior trunk block and interscalene brachial plexus block for arthroscopic shoulder surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0002802
Enrollment
80
Registered
2018-04-17
Start date
2018-04-16
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : 1) interscalene brachial plexus block: local anesthetics (0.5&#37
ropivacaine 15ml with 1:200,000 epinephrine 1ml) were injected between C5 and C6 nerve roots. 2) Superior trunk block: local anesthetics (0.5&#37
ropivacaine 15ml with 1:200,000 epinephrine 1ml) were injected into superior trunk

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult(>19 and =19 years) Patients undergoing arthroscopic shoulder surgery Patients with American Society of Anesthesiologist physical status I,II,III : healthy patients (I), controlled hypertension and diabetes, uncontrolled systemic disease including uncontrolled diabetes (III)

Exclusion criteria

Exclusion criteria: American Society of Anesthesiologist physical status IV, V Children under 18 years old Adults more than 70 years old Pregnant DIabetes Coagulopathy Unstable cardiac disease, congestive heart disease, cardiomyopathy cerebrovascular disease, Systemic Infection, infection on skin at block site chronic pain disorder neural deficit, neuropathy affecting the brachial plexus Patient refusal Allergy to experimental drugs

Design outcomes

Primary

MeasureTime frame
VAS score at 24 h postoperatively

Secondary

MeasureTime frame
duration of analgesia;Opioid consumption

Countries

Korea, Republic of

Contacts

Public ContactRyungA Kang

Samsung Medical Center

ryunga.kang@gmail.com+82-2-3410-2470

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026